SAFETY OF LOW-DOSE PROLONGED INFUSION OF TISSUE PLASMINOGEN ACTIVATOR THERAPY IN PATIENTS WITH THROMBOEMBOLIC EVENTS IN THE INTENSIVE CARE UNIT

Abstract

Objective Thromboembolic events such as acute coronary syndrome related prosthetic heart valve thrombosis, pulmonary artery embolism and renal artery embolism are a rare condition but a major cause of morbidity and mortality. In this study we discussed low-dose thrombolytic therapy, in patients with thromboembolic events in the intensive care unit.